Related Experiment Videos

Impact of preexisting statin use on adhesion molecule expression in patients presenting with acute coronary syndromes

R T Murphy1, J B Foley, N Mulvihill

  • 1Department of Cardiology, St James's Hospital, Dublin, Ireland.

The American Journal of Cardiology
|February 17, 2001
PubMed

Insights

Statin therapy in acute coronary syndromes patients was linked to reduced sP-selectin levels. This finding highlights statins' non-lipid benefits, potentially explaining their significant impact on ischemic heart disease outcomes.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Acute coronary syndromes (ACS) represent a significant global health burden.
  • Statins are widely used for lipid management but possess pleiotropic effects.
  • Platelet and endothelial activation markers are crucial in ACS pathophysiology.

Purpose of the Study:

  • To investigate the association between statin use and sP-selectin levels in ACS patients.
  • To explore the extralipid effects of statins in the context of ischemic heart disease.

Main Methods:

  • A case-control study involving 147 ACS patients.
  • 17 patients on statin therapy were matched with 17 patients not on statin therapy.
  • Measurement of soluble P-selectin (sP-selectin) levels as a marker of platelet and endothelial activation.

Main Results:

  • Statin therapy was associated with significantly lower levels of sP-selectin.
  • This suggests reduced platelet and vascular endothelial activation in statin users.
  • The findings provide evidence for an extralipid mechanism of statin action.

Conclusions:

  • Statin therapy demonstrates an association with reduced platelet and endothelial activation in ACS patients.
  • These extralipid effects may contribute to the observed clinical benefits of statins in ischemic heart disease.
  • Further research into these mechanisms could optimize cardiovascular disease management.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...